<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18850" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Carbon Dioxide Narcosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Drechsler</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>St. Lucie Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Morris</surname>
            <given-names>Jason</given-names>
          </name>
          <aff>PBCGME NOVA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Drechsler declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jason Morris declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>9</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18850.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Carbon dioxide (CO<sub>2</sub>) narcosis is a condition that develops when excessive CO<sub>2</sub> is present in the bloodstream, leading to a depressed level of consciousness. This condition largely results from lung disease, hypoventilation, or environmental exposure. This activity reviews the evaluation and treatment of CO<sub>2</sub> narcosis and highlights the role of the interprofessional healthcare team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the typical presentation of a patient with carbon dioxide narcosis.</p></list-item><list-item><p>Assess&#x000a0;the pathophysiology of carbon dioxide narcosis.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment and management options available for carbon dioxide narcosis.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination amongst interprofessional team members to enhance care delivery for patients with carbon dioxide narcosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18850&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18850">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18850.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hypercapnia, a state of elevated serum carbon dioxide (CO<sub>2</sub>), can manifest as a broad spectrum of disease, the most severe of which is CO<sub>2</sub> narcosis. The delineating feature of CO<sub>2</sub> narcosis is a depressed level of consciousness. It is essential to recognize impending or current CO<sub>2</sub> narcosis; if left untreated, it can result in coma or death. This&#x000a0;topic&#x000a0;primarily focuses on CO<sub>2</sub> narcosis, but it is crucial to appreciate that hypercapnia has multiple end-organ effects contributing to the patient's deterioration. Many etiologies contribute to hypercapnia; the most commonly encountered is chronic obstructive pulmonary disease (COPD). Treatment is focused on fixing the underlying cause and demands an interprofessional approach to optimize patient outcomes.</p>
      </sec>
      <sec id="article-18850.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Overall, the driving mechanism of CO<sub>2</sub> narcosis is acute hypercapnia. The etiology can be extensive, but it can be helpful to divide the potential causes into&#x000a0;3 groups: decreased minute ventilation, increased physiologic dead space, and increased carbon dioxide production.<xref ref-type="bibr" rid="article-18850.r1">[1]</xref>&#x000a0;</p>
        <p>The first group causes decreased minute ventilation (respiratory rate x tidal volume). The central respiratory center in the medulla takes feedback from multiple inputs and integrates them into a respiratory drive, which controls our minute ventilation. Anything that affects the central respiratory center can affect the minute ventilation. Notable etiologies include overdose of sedative medications (narcotics, benzodiazepines, tricyclic antidepressants, etc), stroke, and hypothermia. Although the medulla controls the respiratory drive, many peripheral nerves and respiratory muscles are needed to perform respirations. Decreased respiratory neuromuscular function can decrease minute ventilation. Notable etiologies include Guillain-Barre, myasthenia gravis, amyotrophic lateral sclerosis, myositis, multiple sclerosis, phrenic nerve injury, tetanus, botulism, organophosphates, and ciguatera. Deformity of the thoracic cage can impact tidal volumes, decreasing minute ventilation.</p>
        <p>The second group is anything that increases physiologic dead space (part of the lung that does not participate in gas exchange); this is ventilation without perfusion. This condition can be due to pulmonary capillary compression (positive pressure ventilation) or the destruction of pulmonary capillaries (pulmonary vasculitides, COPD, asthma, interstitial lung disease). A large pulmonary embolism can also cause significant dead space. The third group is anything that increases CO<sub>2</sub> production. It is more likely that this group only partially contributes to hypercapnia, which is not commonly the primary cause but can occur in conditions that increase metabolic rate, sepsis, thyrotoxicosis, or fever.&#x000a0;Environmental exposure to areas rich in carbon dioxide, such as volcanoes or geothermal activity, puts patients at risk for carbon dioxide poisoning. Another unique situation to consider is oxygen-induced hypercapnia, which presents in some patients with COPD when given supplemental oxygen.</p>
      </sec>
      <sec id="article-18850.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The epidemiology of CO<sub>2</sub> narcosis is difficult to ascertain due to all the possible contributing disease entities. Given that most hypercapnia cases result from lung diseases that increase dead space, one can make a generalized estimation. Approximately 5% of the US population is affected by COPD, and it appears to be more prevalent in women than men. Of this 5%, not all patients with COPD develop CO<sub>2</sub> narcosis. The prevalence of COPD increases as age increases but is more common over the age of 45.<xref ref-type="bibr" rid="article-18850.r2">[2]</xref><xref ref-type="bibr" rid="article-18850.r3">[3]</xref><xref ref-type="bibr" rid="article-18850.r4">[4]</xref></p>
      </sec>
      <sec id="article-18850.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The current belief is that hypercapnia changes neurotransmitter levels involved with consciousness. There is a hypothesis that there are increased levels of glutamine and gamma-aminobutyric acid (GABA) and decreased glutamate levels.<xref ref-type="bibr" rid="article-18850.r5">[5]</xref><xref ref-type="bibr" rid="article-18850.r6">[6]</xref><xref ref-type="bibr" rid="article-18850.r7">[7]</xref>&#x000a0;Patient baseline PaCO<sub>2</sub> is important to consider in the development of CO<sub>2</sub> narcosis. Normal individuals do not experience alterations in consciousness until PaCO<sub>2</sub> is greater than 75 mmHg.&#x000a0;Patients with chronic hypercapnia may not experience alterations in consciousness until PaCO<sub>2</sub> exceeds 90 mmHg.<xref ref-type="bibr" rid="article-18850.r8">[8]</xref></p>
        <p>Cerebral autoregulation is a process in which the brain maintains a constant and steady supply of nutrients and oxygen despite changes in cerebral perfusion pressure. CO<sub>2</sub> plays a fundamental role in the regulation of cerebral blood flow. The belief is that changes in PaCO<sub>2</sub> drive changes in the cerebral spinal fluid's pH, causing smooth muscle relaxation or contraction. As PaCO<sub>2</sub> levels rise, cerebral blood vessels dilate; as PaCO<sub>2</sub> levels drop, cerebral blood vessels constrict.<xref ref-type="bibr" rid="article-18850.r9">[9]</xref>&#x000a0;In patients with CO<sub>2</sub> narcosis, the smooth muscle relaxes, causing dilation of cerebral blood vessels, increasing cerebral blood flow, and potentially causing increased intracranial pressure.</p>
        <p>Hypercapnia commonly causes respiratory acidosis. CO<sub>2</sub> combines with H20 to form H2CO3, dissociating into H+ and HCO<sup>3-</sup>. This buffer equation is in constant flux. Giving patients with hypercapnia supplemental bicarbonate worsens their condition if they are not adequately ventilating. The supplemental bicarbonate pushes the acid/base buffer equation towards increased CO2 production; however, if the patient&#x02019;s ventilation is inadequate, the equation moves back towards more H+ production, worsening the acidosis.&#x000a0;With respiratory acidosis, the kidneys try to compensate by increasing H+ secretion, raising the HCO<sup>3-</sup> concentration, assuming the patient has adequate kidney function. In acute respiratory acidosis, the serum HCO<sup>3-</sup> increases 1 mEq/L for every 10 mmHg elevation in PaCO<sub>2</sub>. If PaCO<sub>2</sub> remains elevated for&#x000a0;3 to&#x000a0;5 days despite compensatory mechanisms, it is considered chronic respiratory acidosis. In this state, the serum HCO<sup>3-</sup> increases from 3.5 to 5 mEq/L for every 10 mmHg elevation in PaCO2.<xref ref-type="bibr" rid="article-18850.r10">[10]</xref><xref ref-type="bibr" rid="article-18850.r11">[11]</xref><xref ref-type="bibr" rid="article-18850.r12">[12]</xref><xref ref-type="bibr" rid="article-18850.r13">[13]</xref></p>
        <p>There is a hypothesis that in certain circumstances, high levels of PaCO<sub>2</sub> can be protective; this refers to a mechanical ventilation strategy called permissive hypercapnia, in which hypercapnia is tolerated to achieve other goals while on the mechanical ventilator. This strategy is useful in patients with acute respiratory distress syndrome (ARDS), COPD, and asthma. The ventilator strategy in patients with ARDS involves using low tidal volumes. It is believed low tidal volumes lessen the risk of alveolar overdistention, decreasing the risk of further lung injury.<xref ref-type="bibr" rid="article-18850.r14">[14]</xref><xref ref-type="bibr" rid="article-18850.r15">[15]</xref>&#x000a0;Patients with COPD or asthma undergoing mechanical ventilation are at risk for dynamic auto-inflation or auto-PEEP. This condition occurs when there is incomplete exhalation on the ventilator, and air progressively accumulates in the lungs with each breath, potentially resulting in barotrauma, cardiovascular collapse, or death. One way to prevent auto-PEEP is by decreasing minute ventilation by reducing the respiratory rate or tidal volume.<xref ref-type="bibr" rid="article-18850.r16">[16]</xref><xref ref-type="bibr" rid="article-18850.r17">[17]</xref><xref ref-type="bibr" rid="article-18850.r18">[18]</xref>&#x000a0;In both the strategy for ARDS and obstructive airway disease, minute ventilation requires reduction to prevent adverse effects of mechanical ventilation. As a consequence of these strategies, the patient may develop hypercapnia, which is considered acceptable if the pH remains above 7.2. The data confounds&#x000a0;whether patient outcomes improve by permissive hypercapnia or other concomitant mechanical ventilation goals.<xref ref-type="bibr" rid="article-18850.r19">[19]</xref></p>
        <p>Oxygen-induced hypercapnia can develop in some patients with COPD. Formerly, the belief was that these patients depended on a hypoxemic respiratory drive due to a blunted sensitivity to CO<sub>2</sub>. According to this previous theory, when giving supplemental oxygen to COPD patients, they would develop hypercapnia due to a loss of their hypoxemic respiratory drive with a resultant decrease in alveolar ventilation. However, recent studies support that oxygen-induced hypercapnia in select COPD patients is due to increased dead space, Haldane effect, and decreased minute ventilation.<xref ref-type="bibr" rid="article-18850.r20">[20]</xref><xref ref-type="bibr" rid="article-18850.r21">[21]</xref><xref ref-type="bibr" rid="article-18850.r22">[22]</xref><xref ref-type="bibr" rid="article-18850.r23">[23]</xref><xref ref-type="bibr" rid="article-18850.r24">[24]</xref><xref ref-type="bibr" rid="article-18850.r25">[25]</xref><xref ref-type="bibr" rid="article-18850.r26">[26]</xref>&#x000a0;In these studies, the largest component of acute hypercapnia was due to increased dead space ventilation (increased V/Q mismatch). This mismatch is believed to be due to a loss of hypoxic pulmonary vasoconstriction. Normally, this compensatory mechanism redirects blood to areas of good perfusion to maximize the exchange of oxygen and CO<sub>2</sub> between alveoli and capillaries. Blunting this compensatory mechanism causes a redirection of blood flow from areas of good perfusion to poor perfusion. The second-largest component of acute hypercapnia was due to the Haldane effect. In this mechanism, hemoglobin has a decreased affinity for CO<sub>2</sub>, which appears as a rightward shift on the CO<sub>2</sub>-hemoglobin dissociation curve that occurs with increased oxygen levels. The Haldane effect occurs because CO<sub>2</sub> does not bind as tightly to oxyhemoglobin as deoxyhemoglobin. The last and smallest component of oxygen-induced hypercapnia was attributed to the original theory of decreased minute ventilation.</p>
      </sec>
      <sec id="article-18850.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The initial patient encounter should always begin with evaluating the airway, breathing, and circulation. Once these have been secured and addressed, continue with the history and physical exam. A neurologic exam and Glasgow coma scale (GCS) are necessary.&#x000a0;The severity of the patient's presentation varies depending on the PaCO<sub>2</sub> accumulation in the blood. Initially, with mild hypercapnia, the patient may only present with non-specific headache, mild dyspnea, tachypnea, or somnolence. As higher levels of CO<sub>2</sub> accumulate, patients can become delirious, confused, bradypnea and can ultimately progress to coma once the patient develops a depressed level of consciousness, known as CO<sub>2</sub> narcosis. Acute hypercapnia initially increases the respiratory drive (tachypnea) but, over time, reduces the respiratory drive (bradypnea).<xref ref-type="bibr" rid="article-18850.r27">[27]</xref>&#x000a0;When evaluating the skin, it can have a variable appearance, depending on the patient&#x02019;s respiratory drive. If the patient retains their respiratory drive, their skin color appears normal because they still receive adequate oxygen. However, if the patient&#x02019;s respiratory drive decreases as a result of their hypercapnia, they may become hypoxic with a resultant cyanotic appearance of the skin.</p>
        <p>CO<sub>2</sub> narcosis is classically considered in patients with a history of sedative use or chronic lung diseases that increase dead space, such as COPD. However, there is a wide range of etiologies that can contribute to CO<sub>2</sub> narcosis. Identifying a risk factor or underlying disorder can help with its identification. Perhaps the patient is known to be a drug user or smokes tobacco. In the latter, be on the lookout for clubbing or wheezing. When evaluating the patient, look at the patient's body habitus. Evaluate for thoracic cage abnormalities or obesity. Inquire about a known history of neuromuscular disorders. If the patient just had surgery with anesthesia, consider that the patient was in a state of hypoventilation. An important point is that the patient does not need to be hypoxemic to be hypercapnic. If the patient is on supplemental oxygen and has an acceptable oxygen saturation due to hypoventilation, the patient may retain CO<sub>2</sub>. This situation can exist in COPD. Patients may be compensated with increased breathing work, allowing them to have an acceptable PaO<sub>2</sub>, but due to the tachypnea, there is less time for exhalation, contributing to the hypercapnia. When the patient develops sufficient hypercapnia, the respiratory drive can decrease with subsequent hypoventilation and a decreased level of consciousness. Additionally, giving a hypoxic patient supplemental oxygen in COPD or another hypoventilation state can worsen the hypercapnia.<xref ref-type="bibr" rid="article-18850.r20">[20]</xref><xref ref-type="bibr" rid="article-18850.r21">[21]</xref></p>
      </sec>
      <sec id="article-18850.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The labs and studies obtained help build a complete picture of why the patient has CO<sub>2</sub> narcosis. A complete blood count can be informative for the chronically hypoxic patient, as it can detect polycythemia. Serum chemistry can reveal an elevated bicarbonate level, reflecting the patient's body trying to compensate for the acidosis from chronic hypercapnia. ABG analysis is critical in the evaluation of CO<sub>2</sub> narcosis. A PaCO<sub>2</sub>&#x000a0;greater than 45 mmHg is considered hypercapnia. The accompanying pH indicates whether the patient's hypercapnia is acute or chronic. Acute hypercapnia typically has a pH of&#x000a0;less than 7.35. Chronic hypercapnia has near-normal pH. A toxicology screen, including opiates and benzodiazepines, helps determine a possible cause. Thyroid function tests may reveal findings consistent with hypothyroidism. A chest X-ray should be performed on these patients to evaluate for hyperinflation, flattened diaphragms, thoracic cage abnormalities, or diaphragm abnormalities. CT imaging of the neck or brain should not be done routinely, only in select patients with a high degree of suspicion for a stroke, tumor, or traumatic dissection.<xref ref-type="bibr" rid="article-18850.r8">[8]</xref></p>
      </sec>
      <sec id="article-18850.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>As stated above, the initial patient encounter should always begin with evaluating the airway, breathing, and circulation. After addressing and securing these, the rest of the treatment can proceed. Therapy aims to determine the underlying cause and correct the hypercapnia. If the patient is having a COPD exacerbation, treat the patient with bronchodilators and steroids. In patients with suspected overdose, consider antidotes for reversal of sedative medications such as naloxone for opiate overdose. If the patient has significant pneumonia, including antibiotics in the treatment is necessary. If the patient has developed anaphylaxis that has threatened their airway, they need to be intubated and started on therapies, including H1 and H2 blockers, corticosteroids, and epinephrine. If the patient already has a depressed level of consciousness, with poor respiratory effort or impending respiratory failure, they need to be intubated, followed by mechanical ventilation. Non-invasive ventilation is inappropriate for patients with CO<sub>2</sub> narcosis due to the high risk of aspiration of gastric contents. These patients require admission to the ICU for close monitoring. A repeat ABG analysis is needed to monitor for improvement of PaCO<sub>2</sub> while undergoing mechanical ventilation. If the patient has a new-onset acute hypercapnia, the goal is to correct the normocapnia. If the patient has acute or chronic hypercapnia, the goal is to go back to the patient's baseline levels.<xref ref-type="bibr" rid="article-18850.r8">[8]</xref>&#x000a0;In rare cases where the individual has been exposed to high levels of carbon dioxide, the first step is to remove the individual from the environment and treat it accordingly, as stated above.</p>
      </sec>
      <sec id="article-18850.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Patients who present with a depressed level of consciousness have a broad differential, and many etiologies need to be considered, such as toxins, sedative drugs, metabolic derangements, infections, and supratentorial or infratentorial abnormalities.<xref ref-type="bibr" rid="article-18850.r28">[28]</xref>&#x000a0;The clinician can differentiate CO<sub>2</sub> narcosis by both a depressed level of consciousness and hypercapnia. The diagnosis of CO<sub>2</sub> narcosis and ruling out other disease processes depends on the clinical presentation, lab findings, and imaging.</p>
      </sec>
      <sec id="article-18850.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of CO<sub>2</sub> narcosis depends on many factors, including the patient's age, comorbidities, underlying etiology, presenting symptoms, the severity of symptoms, and response to therapy.</p>
      </sec>
      <sec id="article-18850.s11" sec-type="Complications">
        <title>Complications</title>
        <p>A complication that can occur when managing a patient with CO<sub>2</sub> narcosis is overcorrecting the chronic hypercapnia in a patient with underlying COPD. Overcorrecting can result in alkalemia, reduce respiratory drive, and possibly induce seizures.<xref ref-type="bibr" rid="article-18850.r29">[29]</xref>&#x000a0;Mechanically ventilated patients can develop barotrauma, volutrauma, oxygen toxicity, ventilator-associated pneumonia, or auto-PEEP.<xref ref-type="bibr" rid="article-18850.r29">[29]</xref><xref ref-type="bibr" rid="article-18850.r30">[30]</xref></p>
      </sec>
      <sec id="article-18850.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>It is paramount to identify which patients may develop this as a complication of their underlying disease process. Early recognition of hypercapnia can help prevent further deterioration of the patient's condition into CO<sub>2</sub> narcosis. Prodromal symptoms to recognize before CO<sub>2</sub> narcosis develops can include increased confusion and increased work of breathing. After identification, treatment should be sought immediately. A modifiable risk factor is tobacco abuse. Encourage patients to stop abusing tobacco and provide information regarding nicotine replacement therapy and other cessation treatments.</p>
      </sec>
      <sec id="article-18850.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Caring for a patient who develops CO<sub>2</sub> narcosis can be challenging and requires an interprofessional approach to optimize patient outcomes. The etiology of CO<sub>2</sub> narcosis can be broad and, depending on the cause can produce different challenges for the patient's care. Each team member plays an integral role in patient care, but involvement is largely a function of the underlying cause of hypercapnia. These patients are in the intensive care unit (ICU) and require continuous nurse monitoring. The patient has multiple needs during their care. Chiefly, their condition needs to be addressed ideally by a pulmonologist or an intensivist. Their tools to treat the patient include various modalities such as medications and ventilator management. Nurses play an essential role in these patients by constantly monitoring them, administering medications, and informing the clinicians of any changes in their condition. Nutritionists are also vital to patient care in developing a diet tailored to the patient's needs. This requirement is especially crucial for the patient on a ventilator.</p>
        <p>Additionally, pharmacists must assist with medication optimization and patient education regarding the proper use of their medications. Poor medication compliance and adherence may have contributed to the patient's condition. After the patient has returned to their baseline, some patients may benefit by speaking to case management regarding living and social environments. Many patients who develop CO<sub>2</sub> narcosis have an acute exacerbation of an underlying chronic disease state, such as COPD. These patients may become frustrated and become distressed by their chronic disease. After the condition resolves, speaking to a psychologist may improve the patient's outlook on the future and frame of mind. This is why an interprofessional team approach is needed to address these patients and achieve improved outcomes. While no trial has taken place examining an interprofessional team's role in the care of CO<sub>2</sub> narcosis, data obtained from other sources such as the National Emphysema Treatment Trial (NETT) can be useful and loosely applied as many patients with CO<sub>2</sub> narcosis have a chronic underlying lung disease.<xref ref-type="bibr" rid="article-18850.r31">[31]</xref></p>
      </sec>
      <sec id="article-18850.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18850&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18850">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/lung-disease-respiratory-health/carbon-dioxide-narcosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18850">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18850/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18850">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18850.s15">
        <title>References</title>
        <ref id="article-18850.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Ventilatory failure. Etiology and clinical forms.</article-title>
            <source>Am J Med</source>
            <year>1970</year>
            <month>Apr</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>477</fpage>
            <page-range>477-83</page-range>
            <pub-id pub-id-type="pmid">5444303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hardin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foreman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dransfield</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Hansel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Ramsdell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Washko</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>DeMeo</surname>
                <given-names>D</given-names>
              </name>
              <collab>COPDGene Investigators</collab>
            </person-group>
            <article-title>Sex-specific features of emphysema among current and former smokers with COPD.</article-title>
            <source>Eur Respir J</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>104</fpage>
            <page-range>104-12</page-range>
            <pub-id pub-id-type="pmid">26541532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamil</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pinzon</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Foreman</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Sex and race factors in early-onset COPD.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-4</page-range>
            <pub-id pub-id-type="pmid">23361195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Chronic obstructive pulmonary disease among adults--United States, 2011.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2012</year>
            <month>Nov</month>
            <day>23</day>
            <volume>61</volume>
            <issue>46</issue>
            <fpage>938</fpage>
            <page-range>938-43</page-range>
            <pub-id pub-id-type="pmid">23169314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ang</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Hoop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kazemi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Role of glutamate as the central neurotransmitter in the hypoxic ventilatory response.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>1992</year>
            <month>Apr</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>1480</fpage>
            <page-range>1480-7</page-range>
            <pub-id pub-id-type="pmid">1350580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kneussl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hitzig</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hoop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pappagianopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kazemi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[A model of the central control of respiration].</article-title>
            <source>Wien Klin Wochenschr</source>
            <year>1986</year>
            <month>Sep</month>
            <day>12</day>
            <volume>98</volume>
            <issue>17</issue>
            <fpage>561</fpage>
            <page-range>561-4</page-range>
            <pub-id pub-id-type="pmid">3765644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ang</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Hoop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kazemi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Brain glutamate metabolism during metabolic alkalosis and acidosis.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>2552</fpage>
            <page-range>2552-8</page-range>
            <pub-id pub-id-type="pmid">1362726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davidson</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Banham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gelder</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Glossop</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Creagh-Brown</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dodd</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Felton</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fo&#x000eb;x</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mansfield</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>McDonnell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Sovani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>L</given-names>
              </name>
              <collab>BTS Standards of Care Committee Member, British Thoracic Society/Intensive Care Society Acute Hypercapnic Respiratory Failure Guideline Development Group, On behalf of the British Thoracic Society Standards of Care Committee</collab>
            </person-group>
            <article-title>BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults.</article-title>
            <source>Thorax</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>71 Suppl 2</volume>
            <fpage>ii1</fpage>
            <page-range>ii1-35</page-range>
            <pub-id pub-id-type="pmid">26976648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zuccarello</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rapoport</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>pCO(2) and pH regulation of cerebral blood flow.</article-title>
            <source>Front Physiol</source>
            <year>2012</year>
            <volume>3</volume>
            <fpage>365</fpage>
            <pub-id pub-id-type="pmid">23049512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adrogu&#x000e9;</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Madias</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Secondary responses to altered acid-base status: the rules of engagement.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>920</fpage>
            <page-range>920-3</page-range>
            <pub-id pub-id-type="pmid">20431042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>POLAK</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>HAYNIE</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>HAYS</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>SCHWARTZ</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>Effects of chronic hypercapnia on electrolyte and acid-base equilibrium. I. Adaptation.</article-title>
            <source>J Clin Invest</source>
            <year>1961</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>1223</fpage>
            <page-range>1223-37</page-range>
            <pub-id pub-id-type="pmid">13736670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Yperselle de Striho</surname>
              </name>
              <name>
                <surname>Brasseur</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>De Coninck</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>The "carbon dioxide response curve" for chronic hypercapnia in man.</article-title>
            <source>N Engl J Med</source>
            <year>1966</year>
            <month>Jul</month>
            <day>21</day>
            <volume>275</volume>
            <issue>3</issue>
            <fpage>117</fpage>
            <page-range>117-22</page-range>
            <pub-id pub-id-type="pmid">5943727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brackett</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Wingo</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Muren</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Solano</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Acid-base response to chronic hypercapnia in man.</article-title>
            <source>N Engl J Med</source>
            <year>1969</year>
            <month>Jan</month>
            <day>16</day>
            <volume>280</volume>
            <issue>3</issue>
            <fpage>124</fpage>
            <page-range>124-30</page-range>
            <pub-id pub-id-type="pmid">5782513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walkey</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Goligher</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Del Sorbo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Adhikari</surname>
                <given-names>NKJ</given-names>
              </name>
              <name>
                <surname>Wunsch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Meade</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Uleryk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Talmor</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Brower</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>Supplement_4</issue>
            <fpage>S271</fpage>
            <page-range>S271-S279</page-range>
            <pub-id pub-id-type="pmid">28846440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muthu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sehgal</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Pe&#x000f1;uelas</surname>
                <given-names>&#x000d3;</given-names>
              </name>
              <name>
                <surname>Nin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Muriel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>'Permissive' hypercapnia in ARDS: is it pass&#x000e9;?</article-title>
            <source>Intensive Care Med</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>952</fpage>
            <page-range>952-953</page-range>
            <pub-id pub-id-type="pmid">28439645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thorevska</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Manthous</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Determinants of dynamic hyperinflation in a bench model.</article-title>
            <source>Respir Care</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>49</volume>
            <issue>11</issue>
            <fpage>1326</fpage>
            <page-range>1326-34</page-range>
            <pub-id pub-id-type="pmid">15507167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuxen</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1987</year>
            <month>Oct</month>
            <volume>136</volume>
            <issue>4</issue>
            <fpage>872</fpage>
            <page-range>872-9</page-range>
            <pub-id pub-id-type="pmid">3662241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marini</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Brower</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Auto-peep with low tidal volume.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2003</year>
            <month>Apr</month>
            <day>15</day>
            <volume>167</volume>
            <issue>8</issue>
            <fpage>1150</fpage>
            <page-range>1150-1; author reply 1151</page-range>
            <pub-id pub-id-type="pmid">12684254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Muriel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pe&#x000f1;uelas</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Brochard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lorente</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Raymondos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>R&#x000ed;os</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Violi</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Thille</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Villagomez</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hurtado</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maggiore</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Soto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>D'Empaire</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Matamis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Abroug</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Arabi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sandi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jibaja</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kuiper</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>B&#x000fc;low</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Zeggwagh</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Anzueto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sznajder</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>A</given-names>
              </name>
              <collab>VENTILA Group</collab>
            </person-group>
            <article-title>Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome.</article-title>
            <source>Intensive Care Med</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>200</fpage>
            <page-range>200-208</page-range>
            <pub-id pub-id-type="pmid">28108768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aubier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murciano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Milic-Emili</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pariente</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Derenne</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1980</year>
            <month>Aug</month>
            <volume>122</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-9</page-range>
            <pub-id pub-id-type="pmid">6774639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aubier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murciano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Milic-Emili</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Touaty</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Daghfous</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pariente</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Derenne</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1980</year>
            <month>Nov</month>
            <volume>122</volume>
            <issue>5</issue>
            <fpage>747</fpage>
            <page-range>747-54</page-range>
            <pub-id pub-id-type="pmid">6778278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dick</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sassoon</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Mahutte</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>O2-induced change in ventilation and ventilatory drive in COPD.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>155</volume>
            <issue>2</issue>
            <fpage>609</fpage>
            <page-range>609-14</page-range>
            <pub-id pub-id-type="pmid">9032202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christiansen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Haldane</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>The absorption and dissociation of carbon dioxide by human blood.</article-title>
            <source>J Physiol</source>
            <year>1914</year>
            <month>Jul</month>
            <day>14</day>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>244</fpage>
            <page-range>244-71</page-range>
            <pub-id pub-id-type="pmid">16993252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanson</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Frasch</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease.</article-title>
            <source>Crit Care Med</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-8</page-range>
            <pub-id pub-id-type="pmid">8565533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robinson</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Freiberg</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Regnis</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>IH</given-names>
              </name>
            </person-group>
            <article-title>The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2000</year>
            <month>May</month>
            <volume>161</volume>
            <issue>5</issue>
            <fpage>1524</fpage>
            <page-range>1524-9</page-range>
            <pub-id pub-id-type="pmid">10806149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crossley</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Barrow</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Houston</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Influence of inspired oxygen concentration on deadspace, respiratory drive, and PaCO2 in intubated patients with chronic obstructive pulmonary disease.</article-title>
            <source>Crit Care Med</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>25</volume>
            <issue>9</issue>
            <fpage>1522</fpage>
            <page-range>1522-6</page-range>
            <pub-id pub-id-type="pmid">9295826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PRICE</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Effects of carbon dioxide on the cardiovascular system.</article-title>
            <source>Anesthesiology</source>
            <year>1960</year>
            <season>Nov-Dec</season>
            <volume>21</volume>
            <fpage>652</fpage>
            <page-range>652-63</page-range>
            <pub-id pub-id-type="pmid">13737968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plum</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Posner</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>The diagnosis of stupor and coma.</article-title>
            <source>Contemp Neurol Ser</source>
            <year>1972</year>
            <volume>10</volume>
            <fpage>1</fpage>
            <page-range>1-286</page-range>
            <pub-id pub-id-type="pmid">4664014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cannizzaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Garbin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Clivati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pesce</surname>
                <given-names>LI</given-names>
              </name>
            </person-group>
            <article-title>Correction of hypoxia and hypercapnia in COPD patients: effects on cerebrovascular flow.</article-title>
            <source>Monaldi Arch Chest Dis</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-12</page-range>
            <pub-id pub-id-type="pmid">9151513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Polese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brandi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Intrinsic positive end-expiratory pressure (PEEPi).</article-title>
            <source>Intensive Care Med</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>522</fpage>
            <page-range>522-36</page-range>
            <pub-id pub-id-type="pmid">7560497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18850.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuzma</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meli</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Meldrum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jellen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Butler-Lebair</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koczen-Doyle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rising</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stavrolakes</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brogan</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary care of the patient with chronic obstructive pulmonary disease.</article-title>
            <source>Proc Am Thorac Soc</source>
            <year>2008</year>
            <month>May</month>
            <day>01</day>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>567</fpage>
            <page-range>567-71</page-range>
            <pub-id pub-id-type="pmid">18453373</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
